Analystreport

Repligen (RGEN) is now covered by Roth Mkm. They set a "buy" rating and a $160.00 price target on the stock.

Repligen Corporation  (RGEN) 
Last repligen corporation earnings: 2/20 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: repligen.com/investors